Quantcast

Latest Insulin therapy Stories

2014-05-01 23:03:44

Most health plans consider insulin pump therapy medically necessary when patients meet very specific criteria. Despite the increased use of insulin pump therapy based on recommendations made by the American Association of Diabetes Educators, the American Association of Clinical Endocrinologists, and the American Diabetes Association, there is no official guideline for the initiation of insulin pump use. (PRWEB) May 01, 2014 Technological advances continue to increase the appeal of insulin...

2014-04-15 23:08:18

Market Size - $20.97 bn in 2013, Market Growth - CAGR of 12.4%, Market Trends – Growing penetration of insulin products in Asian markets. View complete report - http://www.grandviewresearch.com/industry-analysis/insulin-market. San Francisco, California (PRWEB) April 15, 2014 The global market for insulin is expected to reach USD 47.54 billion by 2020, according to a new study by Grand View Research, Inc. Growing global prevalence of type I and type II diabetes and the presence of high...

2014-04-14 12:32:44

Conference Call and Webcast at 8:30 a.m. Eastern Time THE WOODLANDS, Texas, April 14, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today positive, top-line results in a Phase 2 clinical trial of LX4211 in type 1 diabetes, which achieved the primary endpoint of reducing mealtime insulin use as well as several secondary endpoints, including improved glycemic control. LX4211 is an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2...

2014-04-10 23:04:51

2014 Deep Research Report on Global and China Insulin Industry is the new market research report added to the online library of DeepResearchReports.com. Dallas, Texas (PRWEB) April 10, 2014 This is a professional and in-depth study on the current state of the Insulin industry in Global and China. The report provides a basic overview of the industry including definitions, applications and industry chain structure. Global market analysis and Chinese domestic market analysis are provided...

2014-04-10 08:29:58

- Experienced Medical Device Executive Will Lead Company Through Scale-Up and International Commercialization of PaQ® Insulin Delivery Device - HORW, Switzerland, April 10, 2014 /PRNewswire/ -- CeQur(®) SA, a leader in simple insulin infusion for people with type 2 diabetes, announced the appointment of Douglas Lawrence as chief executive officer, effective immediately. Lawrence replaces CeQur founder James Peterson, who is retiring from the role, but will continue to serve as vice...

2014-04-09 23:04:33

Diasome Pharmaceuticals, Inc. Announces Two New Board Members Cleveland, Ohio (PRWEB) April 09, 2014 Diasome Pharmaceuticals, Inc. (http://www.diasome.com) has announced that Frank McCaney, CEO of Corpak MedSystems, Inc., and Thomas McDonald, founder and CEO of McDonald Partners LLC, have joined its board of directors. Mr. McCaney’s career includes serving in senior management positions at Thermo Electron Corporation and Viasys Healthcare, where he played a lead role in spinning Viasys...

2014-04-07 23:22:26

GIA announces the release of a comprehensive global report on Insulin Pumps (External) markets. Global market for Insulin Pumps (External) is forecast to reach US$1.7 billion by 2020, buoyed by rising obesity, high prevalence of diabetes, and the subsequent need to improve diabetes management. San Jose, California (PRWEB) April 07, 2014 Follow us on LinkedIn – Insulin Pump therapy, also known as Continuous Subcutaneous Insulin Infusion (CSII) therapy, has gained prominence over the...

2014-04-04 23:29:56

MannKind's AFREZZA takes a big step towards FDA approval. Princeton, NJ (PRWEB) April 03, 2014 PharmApprove, the leading strategic, regulatory, and scientific communications consultancy to the pharmaceutical and biotech industries, congratulates client MannKind Corporation on its successful U.S. Food and Drug Administration (FDA) Endocrine and Metabolic Advisory Committee meeting this week. The committee voted 13 to 1 on April 1 to recommend that MannKind’s AFREZZA® (insulin...

2014-03-27 08:34:50

JERUSALEM, March 27, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the first patient has been enrolled in its U.S. Phase 2a trial for its orally ingestible insulin capsule, ORMD-0801, in the treatment of type 1 diabetes (T1DM). "We are pleased to be initiating this U.S. clinical trial with ORMD-0801 in...

2014-03-26 10:55:43

A study published in Diabetologia (the journal of the European Association for the Study of Diabetes) is the first to provide direct evidence that fetal brain response to a dose of sugar given orally to its mother is associated with the mother's insulin sensitivity. This may indicate that the risk of subsequent obesity and diabetes may be pre-programmed in the womb. The study is by Dr Hubert Preissl and Dr Andreas Fritsche, University of Tübingen, Germany and German Center for Diabetes...


Latest Insulin therapy Reference Libraries

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (1 articles) »
Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.